Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy
Frank A. Cuoco, MD*,
William H. Spencer, III, MD,
Valerian L. Fernandes, MD,
Christopher D. Nielsen, MD,
Sherif Nagueh, MD,
J. Lacy Sturdivant, MD,
Robert B. Leman, MD,
J. Marcus Wharton, MD and
Michael R. Gold, MD, PhD
Medical University of South Carolina, Charleston, South Carolina
|
